Background: Retroperitoneal growths often require surgical exploration for diagnostic and/or therapeutic purposes. Here in, we present our experience in laparoscopic management of retroperitoneal masses and review the literature to assess the feasibility of a minimally invasive approach in this setting. Method: In the last 4 years 8 consecutive patients, aged 46 to 73 years, underwent laparoscopic surgery for isolated retroperitoneal masses at our institution. Medical records were reviewed collecting data regarding clinical presentation, dimensions of the finding, pathology, whether a preoperative biopsy was performed and its results, procedure performed (excision versus incisional biopsy), operative times, estimated blood loss, complications, hospital stay and follow-up. Results: All procedures were successfully completed laparoscopically with no conversions. Mean operative time was 131 minutes. Blood loss was 0-200 mL and blood transfusions were not required. One bowel injury was repaired intraoperatively; postoperative course was uneventful in all cases. Hospital stay ranged from 2 to 7 days. Final pathology was local recurrence of Renal cell carcinoma in 3 cases, 1 lymphoma, 1 sarcoma, 1 schwannoma and 2 retroperitoneal cysts. With an average followup of over 2 years there are no recurrences. Conclusions: Laparoscopic approach is a feasible approach in selected patients with retroperitoneal masses. In our experience, laparoscopy offers a viable and oncologically radical option with excellent results and low morbidity. This minimally invasive approach is likely to become more common practice as the experience grows and new technologies become available.
INTRODUCTION
Laparoscopy is now widely used in urological surgery. As surgical experience grows and more urologists acquire expertise in laparoscopic approach, possible indications for this procedure expand. This is the case of retroperitoneal masses and their management with a minimally invasive surgical technique. Retroperitoneal growths often require surgical exploration for diagnostic and/or therapeutic purposes since in many cases imaging is inconclusive and biopsy, when feasible, can be inadequate. The advantages of laparoscopic surgery over open approach may be exploited in this setting with no compromise of the outcomes.
Herein we present our experience in laparoscopic management of retroperitoneal masses and review the literature.
MATERIAL AND METHODS
In the last 4 years 8 consecutive patients, aged 46 to 73 years, underwent laparoscopic surgery for isolated retroperitoneal masses by a single surgeon (AT) in our institution. Medical records of these patients were reviewed. We collected data regarding clinical presentation, dimensions of the finding, pathology, whether a preoperative biopsy was performed and its results, procedure performed (excision versus incisional biopsy), operative times, estimated blood loss, concomitant procedures, complications, hospital stay and follow-up.
Lesion dimensions were registered using the largest dimension from imaging studies. Operative times were recorded as "skin-to-skin" times; in 2 out of 8 cases additional surgical procedures were performed simultaneously and their operative times were subtracted from total.
Standard surgical technique was used for laparoscopic approach. In a full flank position, lesion side upwards, pneumoperitoneum was established by open technique. Additional 3 trocars were placed in the upper abdomen. The retroperitoneal space was accessed by colon mobilization along the line of Toldt and the mass was identified. The finding was then dissected from adjacent structures with accurate hemostasis. The mass was then detached with adequately wide margins and extracted in an Endobag through an additional incision in the lower abdomen (3 cases) or through an extension of a port incision.
The literature was reviewed using PubMed/Medline database and keywords "laparoscopy" or "laparoscopic", "retroperitoneal" or "retroperitoneum"; lymph node dissections and adrenal surgery were excluded. Relevant abstracts and Author pl. provide citation of Table-4 in the text. articles in english were reviewed and summarized collecting available data as reported for our series. Table 1 summarizes clinical presentation, imaging findings and demographics of the patients in our series.
RESULTS
Of note, in our series 3 cases (37.5%) were found on followup imaging due to history of RCC. It is important to note that only 3 of 8 patients were symptomatic at presentation. Average lesion size (largest diameter on imaging) was 6.88 cm ranging from 2 to 16 cm.
Surgery and postoperative course are reported in Table 2 . In 2 (25%) cases preoperative biopsy was performed and only in one case its result correlated with final pathology diagnosis. Only in one case incisional biopsy was performed whether all other findings were radically excised. All procedures were successfully completed laparoscopically with no conversions. Mean operative time was 131 min (range 60-270 minutes), in two cases concomitant surgery was performed (laparoscopic ventral hernia repair and controlateral open partial nephrectomy in one case, and laparoscopic cholecystectomy in another) and its time was subtracted from total. Blood loss ranged from 0 to 200 mL and blood transfusions were not required. One bowel injury was identified and repaired intraoperatively; postoperative course was uneventful in all cases.
Final pathology was local recurrence of Renal cell carcinoma (RCC) in 3 cases, 1 lymphoma, 1 sarcoma, 1 schwannoma and 2 retroperitoneal cysts (one of adrenal origin). It is of note that in our series malignant pathology accounted for 5 out of 8 cases (62.5%).
Hospital stay ranged from 2 to 7 days (median 3). With an average follow-up of over 2 years there are no recurrences. Patient no. 1 was lost on follow-up after 24 months.
DISCUSSION
Literature review yielded 21 papers of laparoscopic treatment of retroperitoneal masses for a total of 27 cases. Most papers are case reports [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] and there are 3 small series. [19] [20] [21] Table 3 summarizes the data of those cases; unfortunately some papers are incomplete with regards to several data elements. As for today, to the best of our knowledge, this is the largest series of laparoscopic treatment of retroperitoneal masses.
Within the available literature, in roughly one half of the cases (13 out of 27, 48%) the finding of a retroperitoneal process was incidental and patients were asymptomatic. Abdominal or flank pain at presentation accounted for 11 cases, abdominal mass, fever, and epigastric discomfort were the presenting symptoms in 1 case each. In our series only one case presented incidentally, and the most common cause of diagnosis was follow-up imaging for RCC (37.5% of cases). In found publications, average lesion size is reported to be 7.5 cm in its largest diameter, ranging from 2 to 20 cm; malignant masses in those reports are generally smaller (2-10 cm). On our experience malignant masses treated laparoscopically measured 2-5 cm indicating a cautious approach to laparoscopic indications.
Limitations of available preoperative imaging techniques and suboptimal feasibility of image-guided preoperative biopsy account for the fact that only one group 21 reported performing guided biopsies and in that setting its accuracy was quite low. In our series preoperative biopsy was carried out in 2 cases and was accurate in diagnosis in one patient. Those findings emphasize the need of novel techniques to establish a more accurate diagnosis in such challenging cases as retroperitoneal masses. An accurate preoperative diagnosis is essential to formulate an appropriate treatment plan.
Published papers report no conversions and this may be due to extreme experience of the surgical team but publication bias must be taken in consideration. It is understandable however, that the growing experience in laparoscopic surgery increases its efficiency even in those delicate cases. Only one group 21 and ourselves reported incisional biopsies whether all others report complete excisions of the specimen. Considering that only few papers deal with malignant pathology it is to expect that the rate of incisional biopsies is higher than reported. Combining all reported cases (literature and our experience) with malignant pathology we find 3 incisional biopsies and 8 complete excisions. From another point of view, diagnostic laparoscopy is likely to produce more incisional biopsies than reported considering this surgical intervention as the last diagnostic tool available when non invasive techniques have failed.
In the published papers malignant pathology is observed only in 6 out of 27 cases (22.2%) and in those cases radical resection was performed in 4 cases whether in other 2 cases incisional biopsy was carried out. No recurrences are reported in those papers; however this element is to be evaluated against a probable publishing bias. Moreover, in cases with malignant pathology only one group 5 stated the follow-up period and reported the absence of recurrence at 12 months.
We believe that laparoscopy is a viable and valid alternative not only as a diagnostic tool but also as a treatment option in retroperitoneal masses. Clearly, an accurate patient selection is paramount, especially when one deals with possibly malignant finding. There is little question regarding the feasibility of 21 We feel that the advantages of minimally invasive surgery can be extended to selected patients with retroperitoneal masses.
In conclusion, laparoscopic approach is a valid alternative to open procedures in selected patients with retroperitoneal masses. In our experience, laparoscopy offers a viable and oncologically radical option with excellent results and low morbidity. This minimally invasive approach is likely to become more common practice as the experience grows and new technologies become available.
